Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pyrrolidine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115197115A details a novel chiral synthesis route offering high optical purity and scalable manufacturing for pharmaceutical intermediates and cost reduction.
Patent CN1259122A details a novel asymmetric Birch reduction for chiral 3,4-dehydroprolines, offering superior yields and eliminating toxic reagents for cost-effective API manufacturing.
Patent CN101602751A reveals a cost-effective, aqueous-based synthesis for Cinepazide Maleate intermediates, offering significant supply chain and safety advantages.
Patent CN1288133C reveals a 4-step route to Levetiracetam, significantly improving yield and safety over traditional 6-step methods for reliable API supply.
Patent CN116283699B reveals a visible-light driven method for high-purity fluoroalkyl pyrrolidines offering significant cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN116396202A details a safe, scalable synthesis of (2S,4S)-4-fluoropyrrolidine-2-carboxylic acid using DeoxoFluor, offering significant cost reduction in API manufacturing.
Patent CN116396201A details a safe, scalable DeoxoFluor route for (2R,4R)-4-fluoropyrrolidine-2-carboxylic acid, offering significant cost and safety advantages over traditional DAST methods.
Patent CN102603592B reveals a novel DBTA resolution method for chiral aminopyrrolidines, offering high yield and optical purity for pharmaceutical supply chains.
Novel synthesis route for high-purity pharmaceutical intermediate offering safety and scale-up advantages for global supply chains and cost reduction.
Novel synthetic route for KOR antagonist intermediate. High yield, scalable process ensuring supply chain stability and cost efficiency for global pharma partners.
Patent CN112608269B introduces a mild chalcogen weak interaction method for pyrrolidine synthesis, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel metal catalyzed tandem synthesis offers mild conditions and high yields for pharmaceutical intermediates, ensuring supply chain reliability and cost efficiency.
Novel synthesis of Trk inhibitor intermediate CN104672121B offers higher yield and safety. Reliable supply chain partner for scalable API intermediate manufacturing with cost efficiency.
Patent CN115197115B reveals novel chiral synthesis. Enables cost reduction and high purity for pharmaceutical intermediates manufacturing supply chains.
Patent CN103189352A reveals a novel organocatalytic Mannich reaction for high-purity pharmaceutical intermediates, offering significant cost reduction and scalable supply chain solutions.
Patent CN102153501B reveals a metal-free organocatalytic route for chiral pyrrolidines and piperidines, offering significant cost reduction in API manufacturing and supply chain reliability.
Patent CN110256479B reveals a novel Ag/Cu-catalyzed route to chiral silicon pyrrolidines. Discover high-ee synthesis, mild conditions, and scalable manufacturing advantages.
Novel route for (R)-2-(2,5-difluorophenyl)pyrrolidine avoids noble metals, offering cost-effective API manufacturing solutions.
Patent CN113121472A reveals a room-temperature gold catalysis method for N-sulfonyl pyrrolidines, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Novel copper-catalyzed radical coupling method for polysubstituted pyrrolidines offers high yield and mild conditions for CNS drug intermediate manufacturing.